• 1
    Schiller P.W., Nguyen T.M.-D., Berzowska I., Dupuis S., Weltrowska G., Chung N.N., Lemieux C. (2000) Synthesis and in vitro activity profiles of DALDA analogues. Eur J Med Chem;35:895901.
  • 2
    Shimoyama M., Shimoyama N., Zhao G.-M., Schiller P.W., Szeto H.H. (2001) Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1]DALDA. J Pharmacol Exp Ther;297:364371.
  • 3
    Shimoyama M., Szeto H.H., Schiller P.W., Tagaito Y., Tokairin H., Eun C.-M., Shimoyama N. (2009) Differential analgesic effects of a mu-opioid peptide, [Dmt 1]DALDA, and morphine. Pharmacol;83:3337.
  • 4
    Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., Szeto H.H. (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem;279:3468234690.
  • 5
    Zhou M., Wu G., Wu L.-J. (2011) Neuronal and microglial mechanisms of neuropathic pain. Mol Brain;4:31.
  • 6
    Leventhal L., Smith V., Hornby G., Andree T.H., Brandt M.R., Rogers K.E. (2007) Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain. J Pharmacol Exp Ther;320:11781185.
  • 7
    Kim H.K., Park S.K., Zhou J.L., Taglialatela G., Chung K., Coggeshall R.E., Chung J.M. (2004) Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain;111:116124.
  • 8
    Park E.-S., Gao X., Chung J.M., Chung K. (2006) Levels of mitochondrial reactive oxygen species in rat neuropathic spinal dorsal horn neurons. Neurosci Lett;391:108111.
  • 9
    Kim H.Y., Chung J.M., Chung K. (2008) Increased production of mitochondrial superoxide in the spinal cord induces pain behaviors in mice: the effect of mitochondrial electron transport complex inhibitors. Neurosci Lett;447:8791.
  • 10
    Kim S.H., Chung J.M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain;50:355363.
  • 11
    Hargreaves K., Dubner R., Brown F., Flores C., Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain;32:7788.
  • 12
    Xu H., Wang X., Partilla J.S., Bishop-Mathis K., Benaderet T.S., Dersch C.M., Simpson D.S., Prisinzano T.E., Rothman R.B. (2008) Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. Brain Res Bull;77:4954.
  • 13
    Spetea M., Bohotin C.R., Asim M.F., Stübegger K., Schmidhammer H. (2010) In vitro and in vivo pharmacological profile of the 5-benzyl analogue of 14-methoxymetopon, a novel mu opioid analgesic with reduced propensity to alter motor function. Eur J Pharm Sci;41:125135.
  • 14
    Neilan C.L., Janvey A.J., Bolan E., Berezowska I., Nguyen T.M., Schiller P.W., Pasternak G.W. (2003) Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. J Pharmacol Exp Ther;306:430436.
  • 15
    Zhao G.M., Qian X., Schiller P.W., Szeto H.H. (2003) Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. J Pharmacol Exp Ther;307:947954.
  • 16
    Yaksh T.L., Reddy S.V. (1981) Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology;54:451467.
  • 17
    Loomis C.W., Jhamandas K., Milne B., Cervenko F. (1987) Monoamine and opioid interactions in spinal analgesia and tolerance. Pharmacol Biochem Behav;26:445451.
  • 18
    Zhao K., Luo G., Giannelli S., Szeto H.H. (2005) Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl-hydroperoxide in neuronal cell lines. Biochem Pharmacol;70:17961806.
  • 19
    Fidanboylu M., Griffiths L.A., Flatters S.J. (2011) Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One;6:e25212.